• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.

作者信息

Vivas Santiago, Ruiz de Morales José María, Ramos Fernando, Suárez-Vilela Dimas

出版信息

N Engl J Med. 2006 Jun 8;354(23):2514-5. doi: 10.1056/NEJMc053129.

DOI:10.1056/NEJMc053129
PMID:16760460
Abstract
摘要

相似文献

1
Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.阿仑单抗用于一名有肠病相关T细胞淋巴瘤风险的难治性乳糜泻患者。
N Engl J Med. 2006 Jun 8;354(23):2514-5. doi: 10.1056/NEJMc053129.
2
Alemtuzumab for refractory celiac disease.阿仑单抗用于难治性乳糜泻
N Engl J Med. 2006 Sep 28;355(13):1396-7; author reply 1397. doi: 10.1056/NEJMc061784.
3
Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphoma.阿仑单抗与吉西他滨治疗肠病型T细胞淋巴瘤1例的疗效
Br J Haematol. 2008 Jul;142(3):484-6. doi: 10.1111/j.1365-2141.2008.07202.x. Epub 2008 May 24.
4
Sustained, durable responses with alemtuzumab in refractory angioimmunoblastic T-cell lymphoma.阿仑单抗治疗难治性血管免疫母细胞性T细胞淋巴瘤的持续、持久反应。
Leuk Lymphoma. 2010 Jul;51(7):1347-50. doi: 10.3109/10428194.2010.486091.
5
The role of alemtuzumab in the management of T-cell malignancies.阿仑单抗在T细胞恶性肿瘤治疗中的作用。
Semin Oncol. 2006 Apr;33(2 Suppl 5):S44-52. doi: 10.1053/j.seminoncol.2006.01.029.
6
Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia.
Br J Haematol. 2010 Aug;150(4):480-1. doi: 10.1111/j.1365-2141.2010.08218.x. Epub 2010 Apr 28.
7
Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment.阿仑单抗治疗难治性T细胞大颗粒淋巴细胞白血病后的快速持久分子反应
Leuk Res. 2010 Aug;34(8):e197-9. doi: 10.1016/j.leukres.2010.01.019. Epub 2010 Mar 7.
8
Rapid elimination of circulating leukemia cells with a small dose of alemtuzumab in refractory aggressive NK-cell leukemia.
Eur J Haematol. 2007 Jun;78(6):545. doi: 10.1111/j.1600-0609.2007.00855.x. Epub 2007 Apr 5.
9
Remission of adult acute lymphocytic leukaemia with alemtuzumab.
Leukemia. 2004 Sep;18(9):1557-8. doi: 10.1038/sj.leu.2403422.
10
TCRβ clonality improves diagnostic yield of TCRγ clonality in refractory celiac disease.TCRβ 克隆性可提高难治性乳糜泻中 TCRγ 克隆性的诊断率。
J Clin Gastroenterol. 2012 Sep;46(8):675-9. doi: 10.1097/MCG.0b013e31823eff20.

引用本文的文献

1
Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician.用于肠道疾病管理的生物疗法：临床医生的考量
Biologics. 2022 Jun 17;16:67-83. doi: 10.2147/BTT.S335697. eCollection 2022.
2
Hematemesis as an Initial Presentation of Enteropathy-Associated T-Cell Lymphoma.呕血作为肠病相关T细胞淋巴瘤的首发表现
Cureus. 2021 Aug 8;13(8):e16992. doi: 10.7759/cureus.16992. eCollection 2021 Aug.
3
Refractory Celiac Disease Type II: A Case Report and Literature Review.II型难治性乳糜泻：一例报告及文献综述
Front Med (Lausanne). 2020 Dec 3;7:564875. doi: 10.3389/fmed.2020.564875. eCollection 2020.
4
How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.如何管理成人乳糜泻：来自英国国家医疗服务体系（NHS）罕见病协作网络中难治性和顽固性乳糜泻的视角。
Frontline Gastroenterol. 2019 Aug 8;11(3):235-242. doi: 10.1136/flgastro-2019-101191. eCollection 2020.
5
Non-Responsive Coeliac Disease: A Comprehensive Review from the NHS England National Centre for Refractory Coeliac Disease.非应答性乳糜泻：英国国民保健制度英格兰国家难治性乳糜泻中心的全面综述。
Nutrients. 2020 Jan 14;12(1):216. doi: 10.3390/nu12010216.
6
Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease.不耐受麸质饮食用于治疗对常规治疗无反应的乳糜泻患者的适应证和使用方法。
Nutrients. 2017 Oct 18;9(10):1129. doi: 10.3390/nu9101129.
7
Approach to patients with refractory coeliac disease.难治性乳糜泻患者的治疗方法。
F1000Res. 2016 Oct 20;5. doi: 10.12688/f1000research.9051.1. eCollection 2016.
8
Improving outcomes of refractory celiac disease - current and emerging treatment strategies.改善难治性乳糜泻的治疗效果——当前及新出现的治疗策略
Clin Exp Gastroenterol. 2016 Aug 3;9:225-36. doi: 10.2147/CEG.S87200. eCollection 2016.
9
Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.难治性乳糜泻的识别与管理：三级医疗中心经验
Nutrients. 2015 Dec 1;7(12):9896-907. doi: 10.3390/nu7125506.
10
The management of refractory coeliac disease.难治性乳糜泻的治疗管理。
Ther Adv Chronic Dis. 2013 Mar;4(2):77-90. doi: 10.1177/2040622312473174.